Trial site
Southern Neurology
- 13running trials
- 4closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease10 trials
- Mild cognitive impairment5 trials
- Parkinson disease3 trials
- Epilepsy2 trials
- Migraine1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 12 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Eli Lilly and Company3 trials
- Novo Nordisk A/S2 trials
- Xenon Pharmaceuticals Inc.2 trials
- Biogen1 trial
- and 5 more
Running trials
Recruiting
A Study of LY3439539 in Participants With Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Parkinson disease2 recruiting
- Epilepsy1 recruiting
- Mild cognitive impairment1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Completed
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Site data: ClinicalTrials.govUpdated 12 Nov 2026